Study gives new insight on inflammation

August 30, 2012 in Inflammatory disorders

Scientists' discovery of an important step in the body's process for healing wounds may lead to a new way of treating inflammation.

A study published today in details how an international team of researchers led by Monash University's Australian Institute (ARMI) discovered the mechanism, which shuts down the signal triggering the body's initial inflammatory response to injury.

When the body suffers a wound or abrasion, , or leukocytes, travel to the site of the injury to protect the tissue from infection and start repairing the damage. However, this period of inflammation need only be temporary. If the body allows the inflammatory stage to continue for too long, the next phase of healing is compromised.

Previous research identified the initial signal that calls the leukocytes to the site of the injury, but how this early signal was switched off, letting the leukocytes know that they were no longer urgently needed, was unknown. The latest findings show that an enzyme called myeloperoxidase is the key to this process.

The team studied with modified leukocytes and tissues that fluoresced different colours, enabling leukocyte movement and the concentration of to be monitored simultaneously. By observing the tiny, transparent fish under a microscope, the researchers were able to observe individual white blood cells and how they are regulated in the inflammatory phase of the healing process.

Lead researcher Professor Graham Lieschke of ARMI said the findings suggested new possibilities for treating inflammation.

"White blood cell activity is important for determining the balance between repair, scarring and healing. Understanding what regulates leukocyte activity during inflammation should ultimately allow us to manipulate this system and maximise healing and repair," Professor Lieschke said.

"Our research has identified a new pathway to target with anti-inflammatory drugs. There is a significant need for new treatment options as current drugs are not effective in all circumstances."

Professor Lieschke said the findings were especially relevant to understanding and treating the hereditary disease myeloperoxidase deficiency, which affects leukocyte function in approximately one in every 2000 people.

Journal reference: Current Biology search and more info website

Provided by Monash University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Asthma symptoms impair sleep quality and school performance in children

The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study.

Inflammatory disorders created 17 hours ago | popularity not rated yet | comments 0

Inflammatory bowel disease raises risk of melanoma

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Inflammatory disorders created May 20, 2013 | popularity 4 / 5 (1) | comments 0

A new 'on' signal for inflammation

(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause ...

Inflammatory disorders created May 14, 2013 | popularity not rated yet | comments 0 | with audio podcast

New research reveals swimming beneficial for young people with asthma

New research by medical students working in the Breathe Well Centre of Research Excellence at the UTAS School of Medicine has revealed swimming has health benefits for young people with asthma, with no adverse effects on ...

Inflammatory disorders created May 10, 2013 | popularity not rated yet | comments 0

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Inflammatory disorders created May 08, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.